http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005079748-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af31909e69b46dece56438c57ca17076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62a3119a692179555302c0a34599f4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b102401abeeb49d75b8ec1c70d8204c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08324f53a027592ecddef3177e6f7ae5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 2005-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c43d7437b48158a778586f2e08c42e26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad7d749a956acfc0378adec018e60655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e797d798bf8cde5679bfff571057f433
publicationDate 2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005079748-A3
titleOfInvention Pharmaceutical preparation for sustained release of a pharmaceutically active ingredient
abstract Pharmaceutical preparation for sustained release of a pharmaceutically active ingredient A pharmaceutical preparation for sustained release of a pharmaceutically active ingredient(s), which preparation comprises particles having an inner core (1) and a first coating (2) provided thereon, wherein said coating (2) contains a mixture of: (a) between 50% and 95% by weight of a copolymer of ethyl acrylate, methylmethacrylate and trimethylamminoethyl methacrylate chloride in a molar ratio of the three acrylates of 1 : 1.8-2.2 : 0.08­-0.12, preferably of 1:2:0.1, (b) between 2% and 30% by weight of a copolymer of ethylacrylate and methacrylic acid in a molar ratio of 1: 0.8-1.2, preferably of 1:1, and (c) between 1 % and 40% by weight of the pharmaceutically active ingredient.
priorityDate 2004-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6039979-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0720473-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87083814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6371258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226597623

Total number of triples: 29.